Logo image of OPK

OPKO HEALTH INC (OPK) Stock Fundamental Analysis

NASDAQ:OPK - US68375N1037 - Common Stock

1.38 USD
+0.02 (+1.47%)
Last: 9/3/2025, 8:00:02 PM
1.36 USD
-0.02 (-1.45%)
After Hours: 9/3/2025, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OPK. OPK was compared to 102 industry peers in the Health Care Providers & Services industry. The financial health of OPK is average, but there are quite some concerns on its profitability. OPK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OPK has reported negative net income.
OPK had a negative operating cash flow in the past year.
In the past 5 years OPK reported 4 times negative net income.
In multiple years OPK reported negative operating cash flow during the last 5 years.
OPK Yearly Net Income VS EBIT VS OCF VS FCFOPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -8.98%, OPK is doing worse than 73.53% of the companies in the same industry.
The Return On Equity of OPK (-13.66%) is worse than 61.76% of its industry peers.
Industry RankSector Rank
ROA -8.98%
ROE -13.66%
ROIC N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
OPK Yearly ROA, ROE, ROICOPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

Looking at the Gross Margin, with a value of 32.65%, OPK is in the better half of the industry, outperforming 61.76% of the companies in the same industry.
OPK's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OPK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
OPK Yearly Profit, Operating, Gross MarginsOPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPK has been reduced compared to 1 year ago.
Compared to 5 years ago, OPK has more shares outstanding
OPK has a worse debt/assets ratio than last year.
OPK Yearly Shares OutstandingOPK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
OPK Yearly Total Debt VS Total AssetsOPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

OPK has an Altman-Z score of -0.52. This is a bad value and indicates that OPK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.52, OPK is doing worse than 81.37% of the companies in the same industry.
OPK has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
OPK has a Debt to Equity ratio of 0.26. This is in the better half of the industry: OPK outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Altman-Z -0.52
ROIC/WACCN/A
WACC8.64%
OPK Yearly LT Debt VS Equity VS FCFOPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

OPK has a Current Ratio of 3.41. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.41, OPK belongs to the top of the industry, outperforming 86.27% of the companies in the same industry.
OPK has a Quick Ratio of 3.02. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.02, OPK belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.41
Quick Ratio 3.02
OPK Yearly Current Assets VS Current LiabilitesOPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

OPK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.12%.
Looking at the last year, OPK shows a decrease in Revenue. The Revenue has decreased by -7.31% in the last year.
The Revenue has been decreasing by -4.59% on average over the past years.
EPS 1Y (TTM)-12.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1800%
Revenue 1Y (TTM)-7.31%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-13.93%

3.2 Future

OPK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.15% yearly.
OPK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.45% yearly.
EPS Next Y-91.42%
EPS Next 2Y-4.03%
EPS Next 3Y16.15%
EPS Next 5YN/A
Revenue Next Year-7.65%
Revenue Next 2Y-3.5%
Revenue Next 3Y1.73%
Revenue Next 5Y4.45%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OPK Yearly Revenue VS EstimatesOPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
OPK Yearly EPS VS EstimatesOPK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OPK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPK Price Earnings VS Forward Price EarningsOPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPK Per share dataOPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

A more expensive valuation may be justified as OPK's earnings are expected to grow with 16.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.03%
EPS Next 3Y16.15%

More info and screens

0

5. Dividend

5.1 Amount

OPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPKO HEALTH INC

NASDAQ:OPK (9/3/2025, 8:00:02 PM)

After market: 1.36 -0.02 (-1.45%)

1.38

+0.02 (+1.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners30.92%
Inst Owner Change-12.06%
Ins Owners5.17%
Ins Owner Change0%
Market Cap1.10B
Analysts86
Price Target3.98 (188.41%)
Short Float %7.82%
Short Ratio11.41
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-55.19%
Min EPS beat(2)-65.99%
Max EPS beat(2)-44.39%
EPS beat(4)2
Avg EPS beat(4)1.19%
Min EPS beat(4)-65.99%
Max EPS beat(4)110.61%
EPS beat(8)3
Avg EPS beat(8)7.39%
EPS beat(12)6
Avg EPS beat(12)14.29%
EPS beat(16)7
Avg EPS beat(16)-127.95%
Revenue beat(2)0
Avg Revenue beat(2)-7.97%
Min Revenue beat(2)-9.64%
Max Revenue beat(2)-6.31%
Revenue beat(4)1
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-9.64%
Max Revenue beat(4)16.97%
Revenue beat(8)3
Avg Revenue beat(8)-1.29%
Revenue beat(12)6
Avg Revenue beat(12)3.96%
Revenue beat(16)8
Avg Revenue beat(16)5.39%
PT rev (1m)26.21%
PT rev (3m)-2.3%
EPS NQ rev (1m)14.29%
EPS NQ rev (3m)14.29%
EPS NY rev (1m)-14.26%
EPS NY rev (3m)-11.44%
Revenue NQ rev (1m)-3.11%
Revenue NQ rev (3m)-2.86%
Revenue NY rev (1m)-2.62%
Revenue NY rev (3m)-3.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.65
P/FCF N/A
P/OCF N/A
P/B 0.84
P/tB 17.74
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.84
BVpS1.63
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.98%
ROE -13.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.65%
FCFM N/A
ROA(3y)-8.99%
ROA(5y)-5.4%
ROE(3y)-12.84%
ROE(5y)-7.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.21%
GM growth 5Y-3.46%
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.93%
Cap/Sales 2.99%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.41
Quick Ratio 3.02
Altman-Z -0.52
F-Score4
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)21.19%
Cap/Depr(5y)28.79%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1800%
EPS Next Y-91.42%
EPS Next 2Y-4.03%
EPS Next 3Y16.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.31%
Revenue growth 3Y-26.21%
Revenue growth 5Y-4.59%
Sales Q2Q%-13.93%
Revenue Next Year-7.65%
Revenue Next 2Y-3.5%
Revenue Next 3Y1.73%
Revenue Next 5Y4.45%
EBIT growth 1Y-0.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.05%
EBIT Next 3Y30.59%
EBIT Next 5Y26.03%
FCF growth 1Y-135.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-175.56%
OCF growth 3YN/A
OCF growth 5YN/A